SCR-A002, a novel FGFR2b-targeting antibody-drug-conjugate for solid tumors

被引：0

作者：

Fu, Yayuan ^{[1
]}

Ge, Yuanjie ^{[1
]}

Shao, Xiaohui ^{[1
]}

Deng, Qi ^{[1
]}

Xia, Chunlei ^{[1
]}

Tang, Renhong ^{[1
]}

机构：

[1] Jiangsu Simcere Pharmaceut Co Ltd, State Key Lab Neurol & Oncol Drug Dev, Nanjing, Jiangsu, Peoples R China

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e15019

引用

页数：1

共 50 条

[1] Preclinical development of a novel antibody-drug conjugate targeting "cold" tumors
Kaplan, Angelo
Attanasio, Nickolas
Do, To Uyen T.
Swaminathan, Sudha
Bisht, Arnima
Lou, San Lin
Allen, Jason
Boyd, Robert
Ackroyd, James E.
Feldman, Gleb
Rohlff, Christian
Dusek, Rachel L.
[J]. CANCER RESEARCH, 2018, 78 (13)
[2] SYD985, a Novel HER2 Targeting Antibody-Drug-Conjugate, Demonstrates Remarkable Antitumor Activity in Carcinosarcoma.
Black, Jonathan
Schwab, Carlton
Lopez, Salvatore
Cocco, Emiliano
Bellone, Stefania
Bonazzoli, Elena
Menderes, Gulden
Goedings, Peter
Beusker, Patric
van der Lee, Miranda
Timmers, Marco
Dokter, Wim
Litkouhi, Babak
Silasi, Dan-Arin
Ratner, Elena
Azodi, Masoud
Schwartz, Peter
Santin, Alessandro
[J]. REPRODUCTIVE SCIENCES, 2016, 23 : 180A - 180A
[3] In vitro and in vivo activity of a highly potent and novel FGFR2/FGFR4 dual targeting antibody-drug conjugate
Meyer, Matthew J.
Jenkins, David
Batt, David
Mosher, Rebecca
Isaacs, Randi
Hu, Tiancen
Capka, Vladimir
Zhang, Xiamei
Chen, Dongshu
Tang, Lujia
Daley, Mike
Nowakowski, Patrycja
Shim, Yeonju
Jiang, Wei
Ettenberg, Seth
Lees, Emma
[J]. CANCER RESEARCH, 2015, 75
[4] RN927C, a potent site-specific Trop-2 antibody-drug-conjugate (ADC) for treatment of solid tumors
Liu, Shu-Hui
Strop, Pavel
Thomas-Toan Tran
Dorywalska, Magdalena
Delaria, Katherine
Ho, Wei-Hsien
Dushin, Russell
Pons, Jaume
Rajpal, Arvind
Shelton, Dave
[J]. CANCER RESEARCH, 2014, 74 (19)
[5] CKD-703, a novel antibody-drug conjugate targeting cMET with an enhanced therapeutic index in solid tumors
Lee, Kwanwoo
Kim, Sue-Youn
Hong, Hye-Jin
Park, Eunjeong
Park, Jungok
Hong, Seong-Ho
Bae, Daekwon
Ha, Nina
Yeon, Sohn-Ji
Hwang, Inchang
Kim, Semi
Lee, Yoonseok
Lee, Ju-Hee
[J]. CANCER RESEARCH, 2024, 84 (07)
[6] LCB97, an antibody drug conjugate (ADC) targeting a novel tumor antigen for the treatment of multiple solid tumors
Jeong, Yeojin
Spohn, Gunther
Mehli, Flavio
Chung, Chul-Woong
Park, Changsik
[J]. CANCER RESEARCH, 2023, 83 (07)
[7] Preclinical development of NaPi2b-PL2202, a novel camptothecin- based antibody-drug conjugate targeting solid tumors expressing NaPi2b
Horsley, Elizabeth
Jabeen, Asma
Veillard, Nicolas
Havenith, Karin
Janghra, Narinder
Alves, Pedro
Oblette, Cecile
Kirby, Ian
Hogg, Paul W.
Zammarchi, Francesca
de Haan, Lolke
van Berkel, Patrick
[J]. CANCER RESEARCH, 2024, 84 (06)
[8] MEDI7247: A first in class antibody drug conjugate targeting ASCT2 in a range of solid tumors
Schifferli, Kevin P.
Monks, Noel R.
Tammali, Ravinder
Borrok, M. Jack
Flynn, Matthew G.
Hurt, Elaine M.
Coats, Steven R.
Herbst, Ronald
Tice, David A.
Pore, Nabendu
[J]. CANCER RESEARCH, 2018, 78 (13)
[9] Preclinical development of a next generation antibody drug conjugate (ADC) targeting cMET for treatment of solid tumors
Xiao, Liang
Lian, Wei
Song, Shuai
Liu, Qigang
Zong, Qing
Stann, Sasha
Cai, Jiaqiang
Xue, Tongtong
[J]. CANCER RESEARCH, 2024, 84 (06)
[10] NBE-002: A novel anthracycline-based antibody-drug conjugate (ADC) targeting ROR1 for the treatment of advanced solid tumors-A phase 1/2 clinical trial.
Tolcher, Anthony W.
Meric-Bernstam, Funda
McKean, Meredith
Beerli, Roger R.
Waldmeier, Lorenz
Gebleux, Remy
Hellmann, Ina
Chrom, Pawel
Grawunder, Ulf
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

← 1 2 3 4 5 →